CD36 and chronic kidney disease: Regarding LTB4 synthesis, it is still an open gap in macrophage lipid metabolism in CKD.1,25D3 may be suggested as a compound that can attenuate lipid accumulation and therefore prevent lipotoxicity since it can reduce LB formation and CD36-mediated lipid uptake (Figure 3).